Home / Business and Economy / Moderna CMO Steps Down Amid Revenue Shift
Moderna CMO Steps Down Amid Revenue Shift
30 Jan
Summary
- Moderna's Chief Medical Officer Jacqueline Miller is stepping down.
- Miller led the development of the company's COVID-19 vaccine.
- David Berman will assume the role of Chief Development Officer.
Jacqueline Miller, Moderna's Chief Medical Officer, is set to step down from her role effective March 2. Miller was instrumental in the development of the company's mRNA-based COVID-19 vaccine, Spikevax.
Miller joined Moderna in 2020 and has a career history of supporting seven novel vaccine approvals, including Moderna's Spikevax and mRESVIA. Her exit comes as the company navigates a period of declining demand for COVID-19 products.
To manage the transition, Miller will continue to serve as a consultant. David Berman will assume the position of Chief Development Officer on March 2. Berman brings extensive experience from previous senior roles at Immunocore, AstraZeneca, and Bristol-Myers Squibb.
